Form 4: Medtronic Executive Reports Equity Vesting

Medtronic SVP and Chief HR Officer Matthew R. Walter acquired 9,149 ordinary shares following the settlement of performance-vesting units.

Summary

• Matthew R. Walter, SVP and Chief HR Officer at Medtronic, acquired 9,149 ordinary shares on May 26, 2026.
• The acquisition resulted from the settlement of performance-vesting share units granted on July 31, 2023.
• Following this transaction, the reporting person holds a total of 41,529 ordinary shares directly.
• The performance share units vested on April 24, 2026, and were certified on May 26, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding executive equity compensation.

Positives

• The transaction reflects the successful achievement of performance-based equity incentives for a key executive.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that this filing is a routine disclosure of executive compensation settlement, which is standard practice for large-cap medical device companies like Medtronic to align management interests with shareholder value.

Comparison to Industry Standards

• The use of performance-vesting share units is a standard industry practice for executive compensation among S&P 500 healthcare companies.
• The reporting of these transactions via Form 4 is consistent with SEC regulatory requirements for corporate insiders.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity settlement.

Key Dates

Keywords

Medtronic, MDT, Insider Trading, Form 4, Equity Compensation, Executive Compensation